Literature DB >> 33507400

Subversion of Programed Cell Death by Poxviruses.

Heather S Koehler1, Bertram L Jacobs2.   

Abstract

Poxviruses have been long regarded as potent inhibitors of apoptotic cell death. More recently, they have been shown to inhibit necroptotic cell death through two distinct strategies. These strategies involve either blocking virus sensing by the host pattern recognition receptor, ZBP1 (also called DAI) or by influencing receptor interacting protein kinase (RIPK)3 signal transduction by inhibition of activation of the executioner of necroptosis, mixed lineage kinase-like protein (MLKL). Vaccinia virus E3 specifically blocks ZBP1 → RIPK3 → MLKL necroptosis, leaving virus-infected cells susceptible to the TNF death-receptor signaling (e.g., TNFR1 → FADD → RIPK1 → RIPK3 → MLKL), and, potentially, TLR3 → TRIF → RIPK3 → MLKL necroptosis. While E3 restriction of necroptosis appears to be common to many poxviruses that infect vertebrate hosts, another modulatory strategy not observed in vaccinia or variola virus manifests through subversion of MLKL activation. Recently described viral mimics of MLKL in other chordopoxviruses inhibit all three modes of necroptotic cell death. As with inhibition of apoptosis, the evolution of potentially redundant viral mechanisms to inhibit programmed necroptotic cell death emphasizes the importance of this pathway in the arms race between pathogens and their hosts.

Entities:  

Keywords:  Apoptosis; E3L; Interferon; Necroptosis; Poxviruses; Programed cell death; Z-nucleic acid-binding protein

Year:  2021        PMID: 33507400      PMCID: PMC8319220          DOI: 10.1007/82_2020_229

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.737


  131 in total

1.  RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus.

Authors:  Shoko Nogusa; Roshan J Thapa; Christopher P Dillon; Swantje Liedmann; Thomas H Oguin; Justin P Ingram; Diego A Rodriguez; Rachelle Kosoff; Shalini Sharma; Oliver Sturm; Katherine Verbist; Peter J Gough; John Bertin; Boris M Hartmann; Stuart C Sealfon; William J Kaiser; Edward S Mocarski; Carolina B López; Paul G Thomas; Andrew Oberst; Douglas R Green; Siddharth Balachandran
Journal:  Cell Host Microbe       Date:  2016-06-16       Impact factor: 21.023

2.  Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA.

Authors:  H W Chang; B L Jacobs
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

Review 3.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

4.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

5.  The detection of monkeypox in humans in the Western Hemisphere.

Authors:  Kurt D Reed; John W Melski; Mary Beth Graham; Russell L Regnery; Mark J Sotir; Mark V Wegner; James J Kazmierczak; Erik J Stratman; Yu Li; Janet A Fairley; Geoffrey R Swain; Victoria A Olson; Elizabeth K Sargent; Sue C Kehl; Michael A Frace; Richard Kline; Seth L Foldy; Jeffrey P Davis; Inger K Damon
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

Review 6.  Viral modulation of programmed necrosis.

Authors:  William J Kaiser; Jason W Upton; Edward S Mocarski
Journal:  Curr Opin Virol       Date:  2013-06-15       Impact factor: 7.090

7.  Purification of the Xenopus laevis double-stranded RNA adenosine deaminase.

Authors:  R F Hough; B L Bass
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

8.  Rescue of vaccinia virus lacking the E3L gene by mutants of E3L.

Authors:  H W Chang; L H Uribe; B L Jacobs
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

Review 9.  Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity.

Authors:  Geoffrey L Smith; Camilla T O Benfield; Carlos Maluquer de Motes; Michela Mazzon; Stuart W J Ember; Brian J Ferguson; Rebecca P Sumner
Journal:  J Gen Virol       Date:  2013-09-02       Impact factor: 3.891

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more
  2 in total

Review 1.  Viral-mediated activation and inhibition of programmed cell death.

Authors:  Shayla Grace Verburg; Rebecca Margaret Lelievre; Michael James Westerveld; Jordon Marcus Inkol; Yi Lin Sun; Samuel Tekeste Workenhe
Journal:  PLoS Pathog       Date:  2022-08-11       Impact factor: 7.464

Review 2.  Battle Royale: Innate Recognition of Poxviruses and Viral Immune Evasion.

Authors:  Huibin Yu; Ryan C Bruneau; Greg Brennan; Stefan Rothenburg
Journal:  Biomedicines       Date:  2021-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.